Skip Navigation
Skip Ribbon Commands
Skip to main content
NIAID > Topics > Tuberculosis > Research

Tuberculosis (TB)

Research

The New Challenge for TB Research

NIAID’s Role in Addressing TB, Drug-Resistant TB, and TB in People with HIV/AIDS

Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis Research Agenda (PDF)

TB Research at NIAID

Scientific Findings

Tuberculosis Study Could Lead to New Treatments for Immune Diseases

Shortening Treatment in Adults with Non-cavitary Tuberculosis and Two-month Culture Conversion

HIV-1 Infection in Infants Severely Impairs the Immune Response Induced by Bacille Calmette-Guérin Vaccine

Research Features

NIAID-Supported Tuberculosis Researcher Honored for Innovative Research on World TB Day

U.S.-South Korean Collaboration Will Advance TB Care

New Ammunition against an Old Enemy: Multiple Approaches to TB Therapy

Timeline of Events in Development of SQ109

Deciphering the TB Bacterium Genome

Whole Ball of Wax: TB's Distinctive Cell Wall

How Mycobacteria Make Themselves at Home

A Deadly Synergy

U.S.-South Korean Collaboration Will Advance TB Care

TB Genome Knowledge May Lead to Improved Diagnosis

A Timely Test: All-in-One Cartridge May Speed TB Detection

TB Genome Knowledge May Lead to Improved Diagnosis

Closing In: The Long Road to a TB Vaccine

Beating the World’s Most Successful Bug

Engineered Autophagy Boosts BCG Protective Immunity May Result in New Strategies for TB Vaccine Development

Training Rodents to Sniff Out TB

Animal Models Speed TB Drug Development

Engineered Autophagy Boosts Response to BCG Vaccine

Last Updated March 21, 2011